The company won't receive any proceeds from stock sales, but could receive proceeds from the exercise of warrants.
A long list of selling shareholders includes Catalyic Opportunity LLC, which through two series owns just over 4.5M shares.
Shares are down 0.6% after hours.
Now read: Bayer cuts CRISPR stake to 7.2% »
Try Seeking Alpha PREMIUM for unlimited analysis on NDRA